Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03301220 |
|---|---|
| Brief Title: | A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma |
| First Submitted : | September 29, 2017 |
| First Submitted that Met QC Criteria : | September 29, 2017 |
| First Posted : | October 4, 2017 |
| Last Update Submitted that Met QC Criteria : | October 15, 2020 |
| Last Update Posted : | October 19, 2020 |